ROCHE FARMA SA secures contract for Various Medicinal Products - Supply of the active substance called Pertuzumab/Trasuzumab Subcutaneous Vial (Phesgo), for the Pharmacy Service of the University Hospital Complex of the Canary Islands

Spain, March 25 -- Spain based ROCHE FARMA SA has secured contract from Consejeria de Sanidad del Gobierno de Canarias for Various Medicinal Products - Supply of the active substance called Pertuzumab/Trasuzumab Subcutaneous Vial (Phesgo), for the Pharmacy Service of the University Hospital Complex of the Canary Islands. The value of the contract is worth 140559000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....